Stephen Davis Bellicum Pharmaceuticals, Inc (BLCM) insider trading activity

BLCM Quotes by TradingView

Stephen Davis is Director of BELLICUM PHARMACEUTICALS, INC. Currently has a direct ownership of 136,854 shares of BLCM, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 74,739 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
0% 3M change
0% 12M change
Total Value Held $0

STEPHEN DAVIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
BUY
Exercise of conversion of derivative security
-
74,739 Added 35.32%
136,854 Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
-
43,400 Added 41.13%
62,115 Common Stock
Jan 04 2022
BUY
Exercise of conversion of derivative security
-
18,715 Added 50.0%
18,715 Common Stock

Also insider at

HRTX
HERON THERAPEUTICS, INC. Healthcare
Director
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
CEO
SD

Stephen Davis

Director
Houston, TX

Track Institutional and Insider Activities on BLCM

Follow BELLICUM PHARMACEUTICALS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLCM shares.

Notify only if

Insider Trading

Get notified when an Bellicum Pharmaceuticals, Inc insider buys or sells BLCM shares.

Notify only if

News

Receive news related to BELLICUM PHARMACEUTICALS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLCM